Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis-Reference-Cited by-同舟云学术

Treated secondary acute myeloid leukemia: a distinct high-risk subset of AML with adverse prognosis

Published:2017-07-19 Issue:17 Volume:1 Page:1312-1323
ISSN:2473-9529
Container-title:Blood Advances
language:en
Short-container-title:

Author:

Boddu Prajwal¹,Kantarjian Hagop M.¹,Garcia-Manero Guillermo¹,Ravandi Farhad¹,Verstovsek Srdan¹,Jabbour Elias¹,Borthakur Gautam¹,Konopleva Marina¹,Bhalla Kapil N.¹,Daver Naval¹,DiNardo Courtney D.¹,Benton Christopher B.¹,Takahashi Koichi¹,Estrov Zeev¹,Pierce Sherry R.¹,Andreeff Michael¹,Cortes Jorge E.¹,Kadia Tapan M.¹

Affiliation:

1. Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Abstract

Key Pointsts-AML (arising from treated antecedent hematological disorder) is less responsive to currently applied treatment strategies. Future trial designs should accommodate this entity as a distinct category, and patients would be best evaluated on investigational therapies.

Publisher

American Society of Hematology

Subject

Hematology

Link

http://ashpublications.org/bloodadvances/article-pdf/1/17/1312/877603/advances008227.pdf

Reference50 articles.

1. Secondary acute myeloid leukemia;Bennett;Leuk Res,1995

2. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?;Larson;Best Pract Res Clin Haematol,2007

3. Epidemiology and clinical significance of secondary and therapy-related acute myeloid leukemia: a national population-based cohort study;Granfeldt Østgård;J Clin Oncol,2015

4. The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications;Campo;Blood,2011

5. Clinical characterization of acute myeloid leukemia with myelodysplasia-related changes as defined by the 2008 WHO classification system;Weinberg;Blood,2009

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia;Leukemia Research;2024-09

2. Venetoclax is effective for chronic myelomonocytic leukemia blastic transformation with RUNX1 mutation;Hematology;2024-08-20

3. Genomic mutation patterns and prognostic value in de novo and secondary acute myeloid leukemia: A multicenter study from China;International Journal of Cancer;2024-08-07

4. A hybrid protocol CLAG-M, a possible player for the first-line therapy of patients with mixed phenotype acute leukemia. A Polish Adult Leukemia Group experience;Frontiers in Oncology;2024-05-21

5. Targeting hematologic malignancies by inhibiting E-selectin: A sweet spot for AML therapy?;Blood Reviews;2024-05